To screen or not to screen for medullary thyroid cancer? This is (yet) the question. An illustrative case.
Medullary thyroid cancer (MTC) is a rare disease, often displaying an aggressive behavior and a poor prognosis. Serum calcitonin represents the most sensitive marker of MTC and its routine measurement in patients with thyroid nodules allows early detection of occult MTC and appropriate surgical cure...
Main Authors: | Rosaria Ruggeri, Luca Giovannella, Francesco Trimarchi, Alfredo Campennì |
---|---|
Format: | Article |
Language: | English |
Published: |
Accademia Peloritana dei Pericolanti
2018-12-01
|
Series: | Atti della Accademia Peloritana dei Pericolanti - Classe di Scienze Medico-Biologiche |
Subjects: | |
Online Access: | http://cab.unime.it/journals/index.php/APMB/article/view/2014 |
Similar Items
-
Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis
by: Pierpaolo Trimboli, et al.
Published: (2018-06-01) -
False positive results using calcitonin as a screening method for medullary thyroid carcinoma
by: Rafael Loch Batista, et al.
Published: (2013-01-01) -
Cytology of medullary thyroid carcinoma – report of 4 cases
by: Ambawade Vibhuti D
Published: (2013-01-01) -
Calcitonin receptor expression in medullary thyroid carcinoma
by: Virginia Cappagli, et al.
Published: (2017-09-01) -
Metastatic medullary thyroid carcinoma: A case report
by: Mitra Niafar, et al.
Published: (2011-01-01)